Edynara Cruz de Moraes , Marcos V. Palmeira-Mello , Lívia do Carmo Silva , Juliana Santana De Curcio , Alex Marchezini Graça , Jocely Lucena Dutra , Antonio Alonso , Guilherme Rocha Lino de Souza , Alzir Azevedo Batista , Elisângela de Paula Silveira-Lacerda , Pablo José Gonçalves
{"title":"Photodynamic action of Pd(II)/porphyrin complexes against melanoma cells","authors":"Edynara Cruz de Moraes , Marcos V. Palmeira-Mello , Lívia do Carmo Silva , Juliana Santana De Curcio , Alex Marchezini Graça , Jocely Lucena Dutra , Antonio Alonso , Guilherme Rocha Lino de Souza , Alzir Azevedo Batista , Elisângela de Paula Silveira-Lacerda , Pablo José Gonçalves","doi":"10.1016/j.ejmech.2026.118751","DOIUrl":null,"url":null,"abstract":"<div><div>Photodynamic therapy (PDT) is an emerging strategy for cancer treatment and represents a promising approach for melanoma, one of the most aggressive and therapy-resistant forms of skin cancer. In this study, meso-tetra(4-pyridyl)porphyrin complexes coordinated with palladium(II)/diphosphine ligands (Porf@dppe, Porf@dppp, Porf@dppb, and Porf@dppf; dppe = 1,2-bis(diphenylphosphino)ethane, dppp = 1,3-bis(diphenylphosphino)propane, dppb = 1,4-bis(diphenylphosphino)butane, and dppf = 1,1′-bis(diphenylphosphino)ferrocene), previously shown to display favorable lipophilicity and efficient singlet oxygen production, were evaluated against human (A375) and murine (B16-F10) melanoma cells, as well as non-cancerous keratinocytes (HaCaT). Cytotoxicity measured after a 90 min incubation period yielded dark IC<sub>50</sub> values between 0.6 and 8.6 μM, whereas light irradiation (λ = 415 nm, 1.8 J cm<sup>-2</sup>, 36 mW cm<sup>-2</sup>) resulted in markedly lower IC<sub>50</sub> values in the nanomolar range (2–27 nM). Irradiation increased intracellular ROS levels, induced morphological alterations in A375 cells, inhibited long-term proliferation, and reduced cell migration, particularly for Porf@dppb and Porf@dppf. The highest cytotoxicity was observed for Porf@dppf, likely due to the redox-active ferrocene unit promoting Fenton-type reactions and enhanced hydroxyl radical formation. Electron paramagnetic resonance (EPR) spin-trapping experiments confirmed light-induced generation of singlet oxygen, hydroxyl radicals, and superoxide anion, with significantly higher hydroxyl radical production observed for Porf@dppf. The photodynamic activity of these complexes is attributed to efficient ROS production involving simultaneous contributions from both Type I and Type II mechanisms. Moderate binding to bovine serum albumin suggests possible albumin-mediated plasma transport. Overall, palladium(II)/diphosphine porphyrin complexes emerge as promising photosensitizers for melanoma photodynamic therapy.</div></div>","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"309 ","pages":"Article 118751"},"PeriodicalIF":6.7000,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523426001960","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Photodynamic therapy (PDT) is an emerging strategy for cancer treatment and represents a promising approach for melanoma, one of the most aggressive and therapy-resistant forms of skin cancer. In this study, meso-tetra(4-pyridyl)porphyrin complexes coordinated with palladium(II)/diphosphine ligands (Porf@dppe, Porf@dppp, Porf@dppb, and Porf@dppf; dppe = 1,2-bis(diphenylphosphino)ethane, dppp = 1,3-bis(diphenylphosphino)propane, dppb = 1,4-bis(diphenylphosphino)butane, and dppf = 1,1′-bis(diphenylphosphino)ferrocene), previously shown to display favorable lipophilicity and efficient singlet oxygen production, were evaluated against human (A375) and murine (B16-F10) melanoma cells, as well as non-cancerous keratinocytes (HaCaT). Cytotoxicity measured after a 90 min incubation period yielded dark IC50 values between 0.6 and 8.6 μM, whereas light irradiation (λ = 415 nm, 1.8 J cm-2, 36 mW cm-2) resulted in markedly lower IC50 values in the nanomolar range (2–27 nM). Irradiation increased intracellular ROS levels, induced morphological alterations in A375 cells, inhibited long-term proliferation, and reduced cell migration, particularly for Porf@dppb and Porf@dppf. The highest cytotoxicity was observed for Porf@dppf, likely due to the redox-active ferrocene unit promoting Fenton-type reactions and enhanced hydroxyl radical formation. Electron paramagnetic resonance (EPR) spin-trapping experiments confirmed light-induced generation of singlet oxygen, hydroxyl radicals, and superoxide anion, with significantly higher hydroxyl radical production observed for Porf@dppf. The photodynamic activity of these complexes is attributed to efficient ROS production involving simultaneous contributions from both Type I and Type II mechanisms. Moderate binding to bovine serum albumin suggests possible albumin-mediated plasma transport. Overall, palladium(II)/diphosphine porphyrin complexes emerge as promising photosensitizers for melanoma photodynamic therapy.
期刊介绍:
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.